Curcumin Bioavailability in Glioblastoma Patients

N/ACompletedNCT01712542

Johann Wolfgang Goethe University Hospital15 enrolled

Overview

Measuring the bioavailability of orally administered curcumin in the tumors of glioblastoma patients.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Patient Harboring Glioblastoma That Will Undergo Surgery

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients harboring Glioblastoma * Patient will undergo surgery Exclusion Criteria: * BMI \> 30 * Liver and Kidney Function so compromised that medication is prescribed

Locations (1)

Department of Neurosurgery, Johann Wolfgang Goethe-University

Frankfurt am Main, Hesse, Germany

Outcomes

Primary Outcomes

Concentration of Curcumin in Glioblastoma

At the time of surgery

Time frame: At Tumor resection

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.